IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 52.75 USD -1.2% Market Closed
Market Cap: 668.3m USD
Have any thoughts about
IRadimed Corp?
Write Note

Intrinsic Value

The intrinsic value of one IRMD stock under the Base Case scenario is 41.66 USD. Compared to the current market price of 52.75 USD, IRadimed Corp is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

IRMD Intrinsic Value
41.66 USD
Overvaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
IRadimed Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for IRMD cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about IRMD?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about IRadimed Corp

Provide an overview of the primary business activities
of IRadimed Corp.

What unique competitive advantages
does IRadimed Corp hold over its rivals?

What risks and challenges
does IRadimed Corp face in the near future?

Has there been any significant insider trading activity
in IRadimed Corp recently?

Summarize the latest earnings call
of IRadimed Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for IRadimed Corp.

Provide P/S
for IRadimed Corp.

Provide P/E
for IRadimed Corp.

Provide P/OCF
for IRadimed Corp.

Provide P/FCFE
for IRadimed Corp.

Provide P/B
for IRadimed Corp.

Provide EV/S
for IRadimed Corp.

Provide EV/GP
for IRadimed Corp.

Provide EV/EBITDA
for IRadimed Corp.

Provide EV/EBIT
for IRadimed Corp.

Provide EV/OCF
for IRadimed Corp.

Provide EV/FCFF
for IRadimed Corp.

Provide EV/IC
for IRadimed Corp.

Show me price targets
for IRadimed Corp made by professional analysts.

What are the Revenue projections
for IRadimed Corp?

How accurate were the past Revenue estimates
for IRadimed Corp?

What are the Net Income projections
for IRadimed Corp?

How accurate were the past Net Income estimates
for IRadimed Corp?

What are the EPS projections
for IRadimed Corp?

How accurate were the past EPS estimates
for IRadimed Corp?

What are the EBIT projections
for IRadimed Corp?

How accurate were the past EBIT estimates
for IRadimed Corp?

Compare the revenue forecasts
for IRadimed Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of IRadimed Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of IRadimed Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of IRadimed Corp compared to its peers.

Compare the P/E ratios
of IRadimed Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing IRadimed Corp with its peers.

Analyze the financial leverage
of IRadimed Corp compared to its main competitors.

Show all profitability ratios
for IRadimed Corp.

Provide ROE
for IRadimed Corp.

Provide ROA
for IRadimed Corp.

Provide ROIC
for IRadimed Corp.

Provide ROCE
for IRadimed Corp.

Provide Gross Margin
for IRadimed Corp.

Provide Operating Margin
for IRadimed Corp.

Provide Net Margin
for IRadimed Corp.

Provide FCF Margin
for IRadimed Corp.

Show all solvency ratios
for IRadimed Corp.

Provide D/E Ratio
for IRadimed Corp.

Provide D/A Ratio
for IRadimed Corp.

Provide Interest Coverage Ratio
for IRadimed Corp.

Provide Altman Z-Score Ratio
for IRadimed Corp.

Provide Quick Ratio
for IRadimed Corp.

Provide Current Ratio
for IRadimed Corp.

Provide Cash Ratio
for IRadimed Corp.

What is the historical Revenue growth
over the last 5 years for IRadimed Corp?

What is the historical Net Income growth
over the last 5 years for IRadimed Corp?

What is the current Free Cash Flow
of IRadimed Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for IRadimed Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
IRadimed Corp

Current Assets 74.3m
Cash & Short-Term Investments 51.7m
Receivables 10.4m
Other Current Assets 12.2m
Non-Current Assets 20m
PP&E 14.4m
Intangibles 2.9m
Other Non-Current Assets 2.6m
Current Liabilities 8.1m
Accounts Payable 1.4m
Accrued Liabilities 3.7m
Other Current Liabilities 2.9m
Non-Current Liabilities 2.8m
Other Non-Current Liabilities 2.8m
Efficiency

Earnings Waterfall
IRadimed Corp

Revenue
71.3m USD
Cost of Revenue
-16.3m USD
Gross Profit
55m USD
Operating Expenses
-33.7m USD
Operating Income
21.3m USD
Other Expenses
-2.7m USD
Net Income
18.6m USD

Free Cash Flow Analysis
IRadimed Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

IRMD Profitability Score
Profitability Due Diligence

IRadimed Corp's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional ROIC
78/100
Profitability
Score

IRadimed Corp's profitability score is 78/100. The higher the profitability score, the more profitable the company is.

IRMD Solvency Score
Solvency Due Diligence

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

IRadimed Corp's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IRMD Price Targets Summary
IRadimed Corp

Wall Street analysts forecast IRMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IRMD is 61.2 USD with a low forecast of 60.6 USD and a high forecast of 63 USD.

Lowest
Price Target
60.6 USD
15% Upside
Average
Price Target
61.2 USD
16% Upside
Highest
Price Target
63 USD
19% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for IRMD?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for IRMD is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

IRMD Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

IRadimed Corp Logo
IRadimed Corp

Country

United States of America

Industry

Health Care

Market Cap

668.3m USD

Dividend Yield

2.05%

Description

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging (MRI) compatible medical devices. The company is headquartered in Winter Springs, Florida and currently employs 110 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities, both in the United States and internationally.

Contact

FLORIDA
Winter Springs
1025 Willa Springs Dr
+14076778022.0
www.iradimed.com

IPO

2014-07-16 00:00:00

Employees

110

Officers

Founder, Chairman, CEO & President
Mr. Roger E. Susi
CFO & Corporate Secretary
Mr. John F. Glenn
Vice President of Worldwide Sales & Marketing
Mr. Randy Waddell
Executive Vice President of Continuous Improvement & Information Technology
Mr. Chris Williamson
Controller
Mr. Matt Garner
Vice President of Regulatory Affairs & Quality Assurance
Mr. Steve Kachelmeyer
Show More
Vice President of Research & Development
Mr. Lynn Neuhardt
Show Less

See Also

Discover More
What is the Intrinsic Value of one IRMD stock?

The intrinsic value of one IRMD stock under the Base Case scenario is 41.66 USD.

Is IRMD stock undervalued or overvalued?

Compared to the current market price of 52.75 USD, IRadimed Corp is Overvalued by 21%.

Back to Top